Latest News

New drugs offer hope for migraine prevention

Two new studies may offer hope for people with migraines. Both studies involve drugs that are aimed at preventing migraine attacks from occurring, rather than stopping the attacks once they have started. These studies are the first to test monoclonal antibodies for the prevention of migraine, and both are directed against a relatively new target in migraine prevention, the calcitonin gene-related peptide, or CGRP. CGRP has been thought to be important in migraine, but never have drugs been developed to specifically target the protein.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • How does the human brain tackle problems it did not evolve to solve?

  • Patient perceptions of physician compassion measured

  • Reviving drugs with anti-stroke potential, minus side effects

  • Intimate partners with low self-esteem stay in unhappy relationships

  • New compounds protect nervous system from the structural damage characteristic of multiple sclerosis

  • Shake it off? Not so easy for people with depression, new brain research suggests

  • Introverts prefer mountains

  • Research of plain wren duets could help further understand fundamentals of conversation

  • Protein pathway involved in brain tumor stem cell growth identified

  • Altering perception of feeding state may promote healthy aging

  •